New painkiller aims to ease suffering after abdominal surgery
NCT ID NCT06680466
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests a new drug called YZJ-4729 for people experiencing moderate to severe pain after abdominal surgery. Participants are randomly assigned to receive one of several doses of YZJ-4729, a placebo, or the standard painkiller morphine. The goal is to see how well YZJ-4729 relieves pain over 24 hours and to check for any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- YZJ-4729
- What this could lead to
- If successful, YZJ-4729 could offer a new option for managing acute pain after surgery with potentially fewer side effects than morphine.
- What could go wrong
- This is an early-phase trial with a small number of participants, so results may not apply broadly. The drug may not prove more effective or safer than existing treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?